Automated Radiotherapy Treatment Planning System and Method

The European Patent Office published patent EP4272814A1 for RaySearch Laboratories AB, covering a system and method for automated radiotherapy treatment planning. The patent application was filed with claims related to A61N 5/10 (radiotherapy) and G16H 20/40 (health informatics for therapy). This is an informational publication for healthcare providers and medical device manufacturers regarding intellectual property in radiotherapy planning technology.

Device for Assessment of Brain Signals

The European Patent Office published Medtronic's patent application EP4049590A1 for a device designed for the assessment of brain signals. The patent covers innovations related to neural signal processing with applications in brain-computer interfaces and neurostimulation. Designated states include all EU member states plus other European countries.

Genentech cancer therapeutic diagnostic methods patent

Genentech cancer therapeutic diagnostic methods patent

Lespedeza Extract Skin Radiance Patent

European Patent Office published patent application EP3681467A2 for Clariant International Ltd covering the use of Lespedeza plant extract as an active ingredient in cosmetic compositions for increasing skin radiance. The patent application was published March 25, 2026, designating multiple European states.

Anti-PD-1 Monoclonal Antibodies and Obtaining Method

The EPO published patent application EP3770177A1 for anti-PD-1 monoclonal antibodies and methods of obtaining them, filed by Beijing Dongfang Biotech Co., Ltd and Beijing Jingyitaixiang Technology Development Co., Ltd. The patent covers therapeutic applications including cancer treatment and immunological disorders under IPC classifications C07K 16/28, C12N 15/13, and A61P 35/00.

Intestinal Crypt Arrays with Stem Cell and Differentiated Cell Zones - Patent

The European Patent Office published patent application EP3802848A1 for the University of North Carolina at Chapel Hill, covering methods for forming arrays of planar intestinal crypts possessing a stem/proliferative cell compartment and differentiated cell zone. The patent names inventors Albritton, Wang, and Kim, with IPC classifications in C12Q, C12N, A61L, and A61K. Designated states include all EU contracting states.

Liver-Specific Viral Promoters for Gene Therapy

The European Patent Office granted uniQure IP B.V. Patent EP3884049A1 covering liver-specific viral promoters for gene therapy applications. The patent protects proprietary technology for liver-targeted gene therapy vectors developed by the inventors listed. Biotechnology and pharmaceutical companies developing liver-directed gene therapies should review this grant for licensing or freedom-to-operate considerations.

De-differentiated Fibroblast-Conditioned Media for Disc Degeneration Treatment

The European Patent Office published patent application EP3787647A1 for de-differentiated fibroblast-conditioned media for treating or preventing disc degeneration. The patent was filed by FibroBiologics, Inc. with inventors O'Heeron and Ichim. Designated states cover 31 European countries including all EU member states.

Touchlight IP Reprogramming Vectors Patent

The European Patent Office published patent application EP3775227A1 for Touchlight IP Limited, covering reprogramming vectors technology. The patent classifies under C12N 15/85 and C12N 5/074 and is designated across all European member states. No regulatory obligations or compliance deadlines are associated with this patent publication.

Monoclonal Antibody Specifically Binding CD20 - Biocad Patent

The European Patent Office published Patent EP3875486A1 for a monoclonal antibody specifically binding to CD20, filed by Russian biotech company Biocad. The patent covers therapeutic applications including cancer treatments (A61P 35/00, A61P 35/02) and immune disorders (A61P 37/02). The designation extends across 38 European states including DE, FR, GB, IT, ES, NL, and others.